按首字母搜索

产品名字索引 B

• BI 1015550 ( Nerandomilast ) (Catalog# : 230402, Cas# : 1423719-30-5)BI 1015550 ( Nerandomilast ) 是一种口服磷酸二酯酶 4B (PDE4B) 优先抑制剂
• BT44 (Catalog# : 20469, Cas# : 924759-42-2)BT44 is a novel RET agonist for the treatment of experimental neuropathies.
• Brepocitinib ( PF-06700841 ) (Catalog# : 232251, Cas# : 1883299-62-4)Brepocitinib 是一种潜在的 TYK2 和 JAK1双重选择性抑制剂，IC50 分别为
• BIIB068 (Catalog# : 20453, Cas# : 1798787-27-5)
• Baxdrostat (Catalog# : 20451, Cas# : 1428652-17-8)Baxdrostat is an aldosterone synthase inhibitor.
• BMS-986251 (Catalog# : 20445, Cas# : 2114324-48-8)
• BMS-986195 (Catalog# : 20444, Cas# : 1912445 -55-6)
• Branebrutinib (Catalog# : 20428, Cas# : 1912445-55-6)Branebrutinib, also known as BMS-986195, is a potent, covalent, irreversible inhibito
• Bexotegrast ( PLN-74809 ) (Catalog# : 171680, Cas# : 2376257-44-0)Bexotegrast（同义词：PLN-74809）是一种小分子、双重选择性 αVβ1 / α
• 4-溴-2-氰基-6-甲氧基吡啶 (Catalog# : 171653, Cas# : 886372-53-8)4-溴-2-氰基-6-甲氧基吡啶, CAS 886372-53-8
• 1-(4-溴-6-甲基吡啶-2-基)乙-1-酮 (Catalog# : 171454, Cas# : 1060810-24-3)1-(4-溴-6-甲基吡啶-2-基)乙-1-酮, CAS 1060810-24-3.
• BGB 15025 ; BGB-15025 ; BGB15025 (Catalog# : 171452, Cas# : 2766481-17-6)BGB-15025 是一种有效的选择性 HPK1 抑制剂，在多种肿瘤模型中作为
• N-乙基-2-(4-甲酰基苯基)乙酰胺 (Catalog# : 20419, Cas# : 2477812-42-1)
• 497223-19-5 (Catalog# : 20403, Cas# : 497223-19-5)
• Benzeneacetic acid, 4-[[(2,4-dimethylbenzoyl)oxy]methyl]-, methyl ester (Catalog# : 20391, Cas# : 2097334-15-9)
• 497223-19-5 (Catalog# : 20386, Cas# : 497223-19-5)
• 1,10-BIS[4-AZA-1-AZONIABICYCLO[2.2.2]OCTAN-1-YL]DECANE DIBROMIDE (Catalog# : G20381, Cas# : 94630-53-2)
• 6-(苄氧基)-3,4-二氢萘-2(1H)-酮 (Catalog# : 20372, Cas# : 885280-42-2)
• BIBF0775 (Catalog# : L20357, Cas# : 334951-90-5)BIBF0775 is an inhibitor of the transforming growth factor β receptor I (TGFβRI). X
• Blarcamesine HCl (Catalog# : 6111905, Cas# : 195615-84-0)Anavex2-73 is a muscarinic/σ1 ligand. ANAVEX2-73 (0.01-3.0 mg/kg i.p.) alleviated th
• Bunamidine hydrochloride (Catalog# : 20271, Cas# : 1055-55-6)Bunamidine is a anti-parasitic drug, which was approved by FDA for the treatment of t
• BIT225 (Catalog# : 20270, Cas# : 917909-71-8)BIT-225 is a NCp7 zinc finger inhibitor potentially for the treatment of HCV infectio
• BI-3406 (Catalog# : 21234, Cas# : 2230836-55-0)BI-3406 is Potent & Selective SOS1::KRAS Inhibitor (IC50=5 nM), which Opens a New
• BI-187004 (Catalog# : 21224, Cas# : 1303515-32-3)BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit
• Bafetinib (Catalog# : 2021221, Cas# : 887650-05-7)Bafetinib, also known as INNO-406 and NS187, is an orally bioavailable 2-phenylaminop
• BRD0705 (Catalog# : 202112701, Cas# : 2056261-41-5)BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor. BRD0705 ca
• BLU-782 (Catalog# : 20121701, Cas# : 2141955-96-4)
• (2S,5R)-5-氨基-2-甲基哌啶-1-甲酸苄酯盐酸盐 (Catalog# : 20103006, Cas# : 1207853-23-3)
• Benpyrine racemate (Catalog# : 2091907, Cas# : 1333714-43-4)(Rac)-Benpyrine is a racemate of Benpyrine. (Rac)-Benpyrine is a potent and orally ac
• BAY-2416964 (Catalog# : 2091906, Cas# : 2242464-44-2)BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist